Insider buying last 90 days
No open-market insider purchases were filed for RDNT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
RadNet reported record third-quarter 2026 revenue of $638.3 million, up 22.1% year-over-year, with Adjusted EBITDA of $105.0 million, up 23.8%. Adjusted diluted earnings per share came in at $0.30, exceeding analyst estimates, even as revenue itself missed the $644.63 million consensus estimate. The company raised its full-year 2026 guidance for Imaging Center revenue, Adjusted EBITDA, and Free Cash Flow, with growth attributed to its Imaging Centers segment, advanced imaging demand, acquisitions, and its Digital Health business.
RadNet shares closed at $78.38, up 3.1% on the day, sitting above both the 50-day average of $72.64 and the 200-day average of $65.27, with the shorter average above the longer one. The stock trades within its 52-week range of $50.82 to $85.84, and the GekkoIndex reads 45.4, placing it in the Neutral zone. Price sits 3.7% below Gekko Fair Value of $81.39.
The next earnings report is scheduled for 2 March 2027, 106 days away, placing it outside a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the current windows, though one billionaire holder is noted. Seasonality data shows the next 20 trading days have averaged +7.8% over 5 years, rising in 3 of those years. Four analysts covering the stock all rate it buy, with a consensus target of $94.62, implying 20.7% upside from current levels.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
RadNet scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $76.42 is above the 50-day ($72.78) and 200-day ($65.37) averages, and the 50-day is above the 200-day.
See the chart53.9, Neutral
Reading 53.9 is in the Neutral zone.
See the GekkoIndex7.1% below
Price is 7.1% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 106 days
Next report Mar 1, 2027, 106 days away — outside a typical 20-trading-day hold.
See earnings+4.0% on average
From this point in the calendar, the next 20 trading days averaged +4% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
RadNet closed at $76.42 on Nov 13, 2026, +2.6% over the past year, inside a 52-week range of $50.82 to $85.84.
Use the left and right arrow keys to read daily values.
Put RDNT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
RadNet provides outpatient diagnostic imaging services throughout the United States. Its offerings cover magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, general diagnostic radiology, and a range of specialized procedures for patients referred for scans and screenings.
Alongside direct imaging services, RadNet builds and sells computerized systems used in diagnostic imaging, including picture archiving communication systems and related support. The company also develops artificial intelligence tools meant to assist radiologists in reading scans, with applications in mammography as well as lung and prostate cancer detection. Its imaging centers are owned and operated across several states, including Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.
RadNet was founded in 1981 and is headquartered in Los Angeles, California. Its shares are listed on the NASDAQ under the ticker RDNT.
RadNet’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53.9, in the Neutral zone, up 7.7 points over five sessions.
Up 7.7 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 19 | −0.9% | −1.7% | ||
| Accumulation | 218 | +1.5% | +1.3% | ||
| Neutral (current zone) | 398 | +0.5% | +3.6% | ||
| Distribution | 61 | 0.0% | +1.8% | ||
| Selling | 6 | Too few readings yet | |||
Average RDNT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
RadNet trades 7.1% below Gekko Fair Value of $82.30, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what RadNet shares are worth, recalculated every trading day.
$82.30
Gekko Fair Value, Nov 14, 2026
7.1% Undervalued
At the end of Aug 2026 the price was 9.7% below the estimate.
No open-market insider purchases were filed for RadNet, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for RDNT in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in RDNT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
1of the funds Gekko tracks holds RDNT.
RadNet reports on Mar 1, 2027 (106 days away), and beat the EPS estimate in 4 of its last 8 reports.
Mar 1, 2027
106 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 9, 2026 | $0.29 est $0.18 | $622.7M est $610.9M | +6.8% |
| May 11, 2026 | −$0.28 est −$0.19 | $575.6M est $557.9M | −3.8% |
| Mar 2, 2026 | $0.23 est $0.21 | $547.7M est $516.7M | +4.0% |
| Nov 10, 2025 | $0.20 est $0.22 | $522.9M est $494.5M | +0.2% |
| Aug 11, 2025 | $0.31 est $0.17 | $498.2M est $489.0M | +19.2% |
| May 11, 2025 | −$0.35 est −$0.13 | $471.4M est $443.1M | +2.3% |
| Feb 27, 2025 | $0.22 est $0.19 | $477.1M est $461.8M | −6.5% |
| Nov 10, 2024 | $0.13 est $0.15 | $461.1M est $433.9M | +19.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for RadNet is $96.57, +26.4% from the last close, from 6 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 6 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | B. Riley Securities | $108 | +41.3% |
| Nov 10 | KeyBanc | $95 | +24.3% |
| Nov 9 | Barclays | $79 | +3.4% |
| Oct 27 | Barclays | $79 | +3.4% |
| Oct 27 | Truist Financial | $94 | +23.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, RadNet averaged +4.0% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.8% | 3 of 5 |
| Next 10 trading days | +2.6% | 3 of 5 |
| Next 15 trading days | +6.1% | 3 of 5 |
| Next 20 trading days | +4.0% | 2 of 5 |
| Next 30 trading days | +0.3% | 2 of 5 |
For scale, RDNT’s typical 20-trading-day move in either direction is about 7.5%.
RadNet’s market cap is $6.02B and revenue of $2.38B over the last twelve months.
Coverage of RadNet this week reads positive: 5 positive, 4 neutral and 0 negative headlines.
RadNet’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Neutral | 8.5% above |
| GHGuardant Health | Accumulation | 16.4% below |
| SOLVSolventum | Neutral | 17.0% below |
| BTSGBrightSpring Health Services | Neutral | 11.0% above |
| EHCEncompass Health | Neutral | 14.7% above |
| ENSGEnsign | Neutral | 15.6% above |
A peer links to its own page where one exists.
RadNet’s market cap is $6.02B at the Nov 13, 2026 close of $76.42, with 78.78M shares outstanding.
The consensus analyst 12-month price target for RadNet is $96.57, +26.4% from the last close. Of the 6 firms that rated the stock in the last 90 days, 6 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate RadNet is undervalued: the Nov 13, 2026 close of $76.42 is 7.1% below Gekko Fair Value of $82.30. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
RadNet is expected to report on Mar 1, 2027 (106 days away). Analysts expect earnings of $0.28 per share on revenue of $678.4M. RadNet beat the earnings estimate in 4 of its last 8 reports, moving 7.7% on average across the report.
RadNet’s 52-week high is $85.84 and its 52-week low is $50.82; it closed at $76.42 on Nov 13, 2026, +2.6% over the past year. Over the last five years the shares peaked at $93.65 on Nov 11, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and earnings risk), 2 as mixed (gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.